Compare ABR & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABR | GRDN |
|---|---|---|
| Founded | 2003 | 2004 |
| Country | United States | United States |
| Employees | N/A | 3400 |
| Industry | Real Estate Investment Trusts | Retail-Drug Stores and Proprietary Stores |
| Sector | Real Estate | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 2.1B |
| IPO Year | N/A | N/A |
| Metric | ABR | GRDN |
|---|---|---|
| Price | $8.58 | $33.09 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $10.20 | ★ $33.33 |
| AVG Volume (30 Days) | ★ 4.7M | 152.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 13.97% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $19.50 |
| Revenue Next Year | $4.47 | N/A |
| P/E Ratio | ★ $9.29 | $117.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.11 | $17.78 |
| 52 Week High | $12.73 | $37.43 |
| Indicator | ABR | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 66.92 | 56.50 |
| Support Level | $8.31 | $31.82 |
| Resistance Level | $12.13 | $34.98 |
| Average True Range (ATR) | 0.34 | 1.19 |
| MACD | 0.10 | -0.09 |
| Stochastic Oscillator | 98.69 | 50.47 |
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.